Table 2.
Medical care for allergic rhinitis.
| Characteristics | Analysed population N = 1929 |
|
|---|---|---|
| AR follow-up | First consultation for AR | 34.3% |
| Regular follow-up by GP | 57.4% | |
| Regular follow-up by an allergy specialist | 2.0% | |
| At least one consultation with an allergy specialist | 36.9% | |
| Unknown care course | 6.2% | |
| Main consultation reason | Immediate release | 56.6% |
| Treatment renewal | 35.1% | |
| Prescription of long-term treatment | 30.7% | |
| Change/adjustment of ongoing treatment | 16.4% | |
| Ongoing symptomatic treatment | At least one | 64.6% |
| Oral anti-H1 | 59.9% | |
| Intranasal steroids | 27.6% | |
| Intranasal anti-H1 | 14.1% | |
| Intraocular cromone | 11.0% | |
| Intraocular anti-H1 | 10.2% | |
| 1/2/3/>3 therapies | 19.6%/22.5%/17.8%/4.6% | |
| Self-medication | 15.7% | |
| Prescribed symptomatic treatment | At least one | 99.5% |
| Oral anti-H1 | 97.7% | |
| Intranasal steroids | 47.8% | |
| Intranasal anti-H1 | 24.7% | |
| Intraocular cromone | 21.7% | |
| Intraocular anti-H1 | 19.5% | |
| 1/2/3/>3 therapies | 20.1%/34.2%/35.0%/10.7% | |
| Allergen immunotherapy | Yes, whenever | 7.4% |
| Yes, ongoing | 2.2% | |
| Against: | ||
| Mites | 5.9% | |
| Grass pollen | 5.7% | |
| Tree pollens | 2.7% | |
| Herbaceous pollen | 1.8% | |
| Animal dander | 1.6% | |
| Fungal spores | 0.9% | |
| Other | 0.4% | |
| Referred to a specialist | Yes: | 15.1% |
| Allergy specialist | 12.2% | |
| Lung specialist | 2.8% | |
| ENT specialist | 2.6% | |
| Dermatologist | 0.7% | |
| Sick leave prescription | Yes | 1.6% |
| Duration (if yes) | 4.8 ± 2.7 days |
Values are mean ± standard deviation for continuous variables, and % of classes for categorical variables.